MedTrace Logo

The Clinical Therapeutic Effects and Safety of Tissue-engineered Bone

NCT02748343 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2017-11-17

No results posted yet for this study

Summary

The purpose of this study is to compare use of a tissue-engineered bone to use of a standard allograft bone to treat bone defect in patients. The hypothesis is that use of the tissue-engineered bone is effective and safe to treat the bone defect in patients.

Conditions

  • Bone Defect
  • Bone Nonunion

Interventions

DEVICE

allograft bone

Use of the allograft bone to treat the bone defect in patients

DEVICE

tissue-engineered bone

Use of the tissue-engineered bone to treat the bone defect in patients

Sponsors & Collaborators

  • Xijing Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2019-09-30
Completion
2020-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02748343 on ClinicalTrials.gov